Cervical Dysplasia Market

Date: 2016-05

Cervical dysplasia is a precancerous medical condition generally found in women under age 30. Cervical dysplasia results in abnormal cell growth which occurs on the surface lining of the cervix or endocervical canal, the opening between the uterus and the vagina and sometimes is also called cervical intraepithelial neoplasia (CIN). Cervical dysplasia is strongly associated with sexually transmitted human papillomavirus (HPV) infection, and though it is generally found in women under the age of 30, it can develop at any age.

This report identifies the cervical dysplasia market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape and other key aspects with respect to cervical dysplasia market.

Cervical Dysplasia Market

Globally North America dominated the market for cervical dysplasia in 2015 followed by Europe as second largest regional market. Major factor behind dominance of these two regions in cervical dysplasia market place are estimated to be high awareness levels among people about the disease and its treatments as well as well-established healthcare infrastructure with advanced treatments in these regions. Asia- Pacific is expected to witness strong growth in the cervical dysplasia market during the period of study due to increasing reported instances of the disease coupled with increasing awareness and rapidly developing healthcare infrastructure in the region especially in major developing economies like India and China.

This report on global cervical dysplasia also covers different type cervical dysplasia, and market size in various geographical regions.

The report covers major types of cervical dysplasia, some of the major cervical dysplasia types are as follows: low-grade SIL, or LSIL (Squamous Intraepithelial Lesion), high-grade SIL, or HSIL, Cancer Bound SIL and Atypical glandular cells (AGUS)
This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for cervical dysplasia in each of the region.

This report identifies all the major companies operating in the global cervical dysplasia market. Some of the major companies’ profiles in detail are as follows:

Helix BioPharma Corp.
PDS Biotechnology Corporation
GlaxoSmithKline plc
Inovio Biomedical Corporation
Photocure ASA

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample